New test predicts how cancers will respond to chemotherapy
A new DNA test could one day help doctors find which chemotherapy drugs are most likely to work for their patients, according to research we helped fund. It works by […]
Is there a ribosomal weakness in cancer?
Once thought too conserved to be a therapeutic target for cancer, new insights could reveal ribosomal biogenesis to be an Achilles heel. Faraz K. Mardakheh gives us a breakdown… Ribosomes […]
Understanding CAFs to improve radiotherapy outcomes
We really need to further unpick the complexity of cancer-associated fibroblasts if we want to improve radiotherapy outcomes says Anna Wilkins. Here she talks about the hope and the challenges […]
The stellar mission taking on cellular plasticity in bowel cancer
Backed by £5.5m of funding from CRUK and its partners, the hugely ambitious CRC-STARS programme aims to revolutionise how bowel cancer is treated. Much has been written about the dawn […]
Beyond the genome: Harnessing the power of super-enhancers for blood cancer
The mysteries of the epiregulome need to be tackled head-on if we are to get new precision treatments for blood cancers says Lisa Russell. Here she takes us through the […]
Role of the periphery and non-neuronal cells in Parkinson’s pathogenesis
This online seminar will focus on the role of the periphery and non-neuronal cells in Parkinson’s pathogenesis, offering key insights and an opportunity for further discussion. The seminar will be […]